REPAGLINIDE KRKA
Tablet
Compare
|
EU/1/09/579/7-12
Authorised: 04/11/2009
Krka d.d., Novo mesto
|
SPC
PIL
IPAR
|
REPAGLINIDE TEVA
Tablet
Compare
|
EU/1/09/530/11-15
Authorised: 29/06/2009
Teva B.V.
|
SPC
PIL
IPAR
|
REPAGLINIDE TEVA
Tablet
Compare
|
EU/1/09/530/1-5
Authorised: 29/06/2009
Teva B.V.
|
SPC
PIL
IPAR
|
REPAGLINIDE TEVA
Tablet
Compare
|
EU/1/09/530/6-10
Authorised: 29/06/2009
Teva Pharma B.V.
|
SPC
PIL
IPAR
|
Repatha
Solution for injection
Compare
|
EU/1/15/1016/001-005
Authorised: 17/07/2015
Amgen Europe B.V.
|
SPC
PIL
IPAR
|
Repatha
Solution for injection
Compare
|
EU/1/15/1016/006-007
Authorised: 17/02/2017
Amgen Europe B.V.
|
SPC
PIL
IPAR
|
REPEVAX, suspension for injection, in pre-filled syringe Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content)
Suspension for injection in pre-filled syringe
Compare
|
PA2131/006/001
Authorised: 25/07/2003
Sanofi Pasteur
|
SPC
PIL
|
REPLAGAL 1MG/ML
Concentrate for solution for infusion
Compare
|
EU/1/01/189/001
Authorised: 03/08/2001
Takeda Pharmaceuticals International AG Ireland Branch
|
SPC
PIL
IPAR
EdM
|
REPSO
Film-coated tablet
Compare
|
EU/1/11/674/006-010
Authorised: 14/03/2011
Teva B.V.
|
SPC
PIL
IPAR
|
Requip 0.25 mg film-coated tablets
Film-coated tablet
Compare
|
PA1077/037/001
Authorised: 03/12/1996
GlaxoSmithKline (Ireland) Limited
|
SPC
PIL
|
Requip 1 mg film-coated tablets
Film-coated tablet
Compare
|
PA1077/037/003
Authorised: 03/12/1996
GlaxoSmithKline (Ireland) Limited
|
SPC
PIL
|
Requip 2 mg film-coated tablets
Film-coated tablet
Compare
|
PA1077/037/004
Authorised: 03/12/1996
GlaxoSmithKline (Ireland) Limited
|
SPC
PIL
|
Requip 5 mg film-coated tablets
Film-coated tablet
Compare
|
PA1077/037/005
Authorised: 03/12/1996
GlaxoSmithKline (Ireland) Limited
|
SPC
PIL
|
Requip-Modutab 2 mg Prolonged-Release Tablets
Prolonged-release tablet
Compare
|
PA1077/037/006
Authorised: 01/02/2008
GlaxoSmithKline (Ireland) Limited
|
SPC
PIL
EdM
|
Requip-Modutab 2 mg Prolonged-Release Tablets
Prolonged-release tablet
Compare
|
PPA0465/279/002
Authorised: 20/09/2013
PCO Manufacturing Ltd.
|
SPC
PIL
|
Requip-Modutab 2 mg Prolonged-Release Tablets
Prolonged-release tablet
Compare
|
PPA1463/163/001
Authorised: 07/05/2021
IMED Healthcare Ltd.
|
SPC
PIL
|
Requip-Modutab 4 mg Prolonged-Release Tablets
Prolonged-release tablet
Compare
|
PPA1463/163/002
Authorised: 07/05/2021
IMED Healthcare Ltd.
|
SPC
PIL
|
Requip-Modutab 4 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PPA2306/002/002
Authorised: 25/01/2019
Originalis B.V.
|
SPC
PIL
|
Requip-Modutab 4 mg Prolonged-Release Tablets
Prolonged-release tablet
Compare
|
PPA0465/279/003
Authorised: 20/09/2013
PCO Manufacturing Ltd.
|
SPC
PIL
|
Requip-Modutab 4 mg Prolonged-Release Tablets
Prolonged-release tablet
Compare
|
PA1077/037/008
Authorised: 01/02/2008
GlaxoSmithKline (Ireland) Limited
|
SPC
PIL
EdM
|